Precision Oncology Market

Precision Oncology Market Size, Share, Growth Analysis, By Product Type(Diagnostics, Therapeutics), By Cancer Type(Breast Cancer, Colorectal Cancer), By End-use(Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies), By Region(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35H2048 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Precision Oncology Market Insights

Market Overview:

The global precision oncology market was valued at USD 96.4 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.7% during the forecast period from 2023 to 2030. The growth of the market is being driven by factors such as advances in technology, a rapid demand for diagnostic products that provide effective clinical results, minimize side effects of therapeutics in cancer patients, and avoid specific drug resistance. Additionally, expanding research activities, early breast cancer detection, and improvements in patient overall prognosis are expected to increase the demand for precision oncology products.

Precision Oncology Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Biotechnology by segment aggregation, the contribution of the Biotechnology in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Precision Oncology was estimated to be valued at US$ XX Mn in 2021.

The Precision Oncology Market is estimated to grow at a CAGR of XX% by 2028.

The Precision Oncology Market is segmented on the basis of Product Type, Cancer Type, End-use, Region.

Based on region, the Precision Oncology Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Precision Oncology Market are Thermo Fisher Scientific Inc., Invitae Corporation, Qiagen N.V., Illumina, Inc., Laboratory Corporation Of America Holding, Exact Sciences Corporation, Rain Oncology Inc., Strata Oncology, Inc., Xilis, Inc., Variantyx, Inc..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Precision Oncology Market

Product ID: UCMIG35H2048

$5,300
BUY NOW GET FREE SAMPLE